Ubiquitous Gasp1 overexpression in mice leads mainly to a hypermuscular phenotype

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Monestier, Olivier ^a,b   Brun, Caroline ^a,b   Heu, Katy ^a,b   Passet, Bruno ^c   Malhouroux, Mélanie ^a,b   Magnol, Laetitia ^a,b   Vilotte, Jean Luc ^c   Blanquet, Véronique ^a,b  

^a UNIVERSITÉ DE LIMOGES   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c UMR1313 GÉNÉTIQUE ANIMALE ET BIOLOGIE INTÉGRATIVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; FOLLISTATIN; GROWTH AND DIFFERENTIATION FACTOR ASSOCIATED SERUM PROTEIN 1; MYOSTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SIZE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE MODEL; ENHANCER REGION; FAT MASS; FEMALE; GAIN OF FUNCTION MUTATION; GASP1 GENE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN CYTOMEGALOVIRUS; HYPERPLASIA; IMMEDIATE EARLY GENE; LEAN BODY WEIGHT; LIPID STORAGE; MALE; MOLECULAR INTERACTION; MORPHOMETRICS; MUSCLE CELL; MUSCLE HYPERTROPHY; MUSCLE MASS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERINATAL PERIOD; PROMOTER REGION; RECTUS FEMORIS MUSCLE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, VIRAL; CARRIER PROTEINS; CYTOMEGALOVIRUS; FOLLISTATIN; GENE EXPRESSION REGULATION; IMMEDIATE-EARLY PROTEINS; MICE; MICE, TRANSGENIC; MUSCLE FIBERS, SKELETAL; MUSCLE HYPERTONIA; MYOSTATIN; PHENOTYPE; PROMOTER REGIONS, GENETIC; QUADRICEPS MUSCLE; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

HUMAN HERPESVIRUS 5; MUS; MUS MUSCULUS;

EID: 84867220538     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-541     Document Type: Article

References (39)

1. Barberi L, Dobrowolny G, Pelosi L, Giacinti C, Musarò A. Muscle involvement and IGF-1 signaling in genetic disorders: new therapeutic approaches. Endocr Dev 2009, 14:29-37.
2. Minetti GC, Colussi C, Adami R, Serra C, Mozzetta C, Parente V, Fortuni S, Straino S, Sampaolesi M, Di Padova M, Illi B, Gallinari P, Steinkühler C, Capogrossi MC, Sartorelli V, Bottinelli R, Gaetano C, Puri PL. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 2006, 12:1147-1150. 10.1038/nm1479, 16980968.
3. Kota J, Handy CR, Haidet AM, Montgomery CL, Eagle A, Rodino-Klapac LR, Tucker D, Shilling CJ, Therlfall WR, Walker CM, Weisbrode SE, Janssen PM, Clark KR, Sahenk Z, Mendell JR, Kaspar BK. Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates. Sci Transl Med 2009, 1:6ra15. 10.1126/scitranslmed.3000112, 2852878, 20368179.
4. Wolfman NM, McPherron AC, Pappano WN, Davies MV, Song K, Tomkinson KN, Wright JF, Zhao L, Sebald SM, Greenspan DS, Lee SJ. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci USA 2003, 100:15842-15846. 10.1073/pnas.2534946100, 307655, 14671324.
5. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2003, 300:965-971. 10.1016/S0006-291X(02)02953-4, 12559968.
6. Liu CM, Yang Z, Liu CW, Wang R, Tien P, Dale R, Sun LQ. Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice. Gene Ther 2008, 15:155-160. 10.1038/sj.gt.3303016, 18033313.
7. Murphy KT, Koopman R, Naim T, Leger B, Trieu J, Ibebunjo C, Lynch GS. Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. FASEB J 2010, 24:4433-4442. 10.1096/fj.10-159608, 20624929.
8. Li Z, Zhao B, Kim YS, Hu CY, Yang J. Administration of a mutated myostatin propeptide to neonatal mice significantly enhances skeletal muscle growth. Mol Reprod Dev 2010, 77:76-82.
9. Matsakas A, Foster K, Otto A, Macharia R, Elashry MI, Feist S, Graham I, Foster H, Yaworsky P, Walsh F. Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice. Neuromuscul Disord 2009, 19:489-499. 10.1016/j.nmd.2009.06.367, 19541486.
10. Qiao C, Li J, Jiang J, Zhu X, Wang B, Xiao X. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum Gene Ther 2008, 19:241-254. 10.1089/hum.2007.159, 18288893.
11. Hu S, Chen C, Sheng J, Sun Y, Cao X, Qiao J. Enhanced muscle growth by plasmid-mediated delivery of myostatin propeptide. J Biomed Biotechnol 2010, 2010:862591. 2840606, 20300438.
12. Morine KJ, Bish LT, Pendrak K, Sleeper MM, Barton ER, Sweeney HL. Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice. PLoS One 2010, 5:e9176. 10.1371/journal.pone.0009176, 2820101, 20161803.
13. Haidet AM, Rizo L, Handy C, Umapathi P, Eagle A, Shilling C. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA 2008, 105:4318-4322. 10.1073/pnas.0709144105, 2393740, 18334646.
14. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001, 98:9306-9311. 10.1073/pnas.151270098, 55416, 11459935.
15. Lee SJ. Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS One 2007, 2:e789. 10.1371/journal.pone.0000789, 1949143, 17726519.
16. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem 2000, 275:40788-40796. 10.1074/jbc.M006114200, 11010968.
17. Hill JJ, Qiu Y, Hewick RM, Wolfman NM. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: A novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 2003, 17:1144-1154. 10.1210/me.2002-0366, 12595574.
18. Kondás K, Szláma G, Trexler M, Patthy L. Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11. J Biol Chem 2008, 283:23677-23684. 10.1074/jbc.M803025200, 3259755, 18596030.
19. Szláma G, Kondás K, Trexler M, Patthy L. WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activity. FEBS J 2010, 277:5040-5050. 10.1111/j.1742-4658.2010.07909.x, 21054789.
20. Trexler M, Bányai L, Patthy L. Distinct expression pattern of two related human proteins containing multiple types of protease-inhibitory modules. Biol Chem 2002, 383:223-228.
21. Brooke MH, Kaiser KK. Muscle fiber types: how many and what kind?. Arch Neurol 1970, 23:369-379. 10.1001/archneur.1970.00480280083010, 4248905.
22. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002, 420:418-421. 10.1038/nature01154, 12459784.
23. Wagner KR, McPherron AC, Winik N, Lee SJ. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 2002, 52:832-836. 10.1002/ana.10385, 12447939.
24. Siriett V, Platt L, Salerno MS, Ling N, Kambadur R, Sharma M. Prolonged absence of myostatin reduces sarcopenia. J Cell Physiol 2006, 209:866-873. 10.1002/jcp.20778, 16972257.
25. Wagner KR, Liu X, Chang X, Allen RE. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 2005, 102:2519-2524. 10.1073/pnas.0408729102, 548322, 15699335.
26. Burks TN, Cohn RD. Role of TGF-β signaling in inherited and acquired myopathies. Skeletal Muscle 2011, 4:19.
27. Yang J, Ratovitski T, Brady JP, Solomon MB, Wells KD, Wall RJ. Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev 2001, 60:351-361. 10.1002/mrd.1097, 11599046.
28. Zhu X, Hadhazy M, Wehling M, Tidball JG, McNally EM. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett 2000, 474:71-75. 10.1016/S0014-5793(00)01570-2, 10828454.
29. Yang W, Zhang Y, Li Y, Wu Z, Zhu D. Myostatin Induces Cyclin D1 Degradation to Cause Cell Cycle Arrest through a Phosphatidylinositol 3-Kinase/AKT/GSK-3β Pathway and Is Antagonized by Insulin-like Growth Factor 1. J Biol Chem 2007, 282:3799-3808.
30. Ji M, Zhang Q, Ye J, Wang X, Yang W, Zhu D. Myostatin induces p300 degradation to silence cyclin D1 expression through the PI3K/PTEN/Akt pathway. Cell Signal 2008, 20:1452-1458. 10.1016/j.cellsig.2008.03.013, 18472397.
31. Chelh I, Meunier B, Picard B, Reecy MJ, Chevalier C, Hocquette JF, Cassar-Malek I. Molecular profiles of Quadriceps muscle in myostatin-null mice reveal PI3K and apoptotic pathways as myostatin targets. BMC Genomics 2009, 10:196. 10.1186/1471-2164-10-196, 2684550, 19397818.
32. Relaix F, Montarras D, Zaffran S, Gayraud-Morel B, Rocancourt D, Tajbakhsh S, Mansouri A, Cumano A, Buckingham M. Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J Cell Biol 2006, 172:91-102. 10.1083/jcb.200508044, 2063537, 16380438.
33. Girgenrath S, Song K, Whittemore LA. Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle. Muscle Nerve 2005, 31:34-40. 10.1002/mus.20175, 15468312.
34. Hennebry A, Berry C, Siriett V, O'Callaghan P, Chau L, Watson T, Sharma M, Kambadur R. Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression. Am J Physiol Cell Physiol 2009, 296:C525-C534.
35. McPherron AC, Huynh TV, Lee SJ. Redundancy of myostatin and growth/differentiation factor 11 function. BMC Dev Biol 2009, 9:24. 10.1186/1471-213X-9-24, 2666675, 19298661.
36. Elashry MI, Otto A, Matsakas A, El-Morsy SE, Patel K. Morphology and myofiber composition of skeletal musculature of the forelimb in young and aged wild type and myostatin null mice. Rejuvenation Res 2009, 12:269-281. 10.1089/rej.2009.0870, 19725775.
37. McPherron AC, Lee SJ. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 2002, 109:595-601. 150888, 11877467.
38. Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 2002, 291:701-706. 10.1006/bbrc.2002.6500, 11855847.
39. Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, McPherron AC. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 2009, 4:e4937. 10.1371/journal.pone.0004937, 2654157, 19295913.